Pharma’s response to COVID: GSKA few months into the pandemic, the world is now moving beyond managing the crisis, with more focus Share XPharma’s response to COVID: GSKhttps://pharmaphorum.com/views-analysis-sales-marketing/pharmas-response-to-covid-gsk/
Novo Nordisk: Prevention, digital tools and collaboration to define the future of diabetesIn our latest UK Leaders article Pinder Sahota, UK general manager at Novo Nordisk, tells us how he Share XNovo Nordisk: Prevention, digital tools and collaboration to define the future of diabeteshttps://pharmaphorum.com/views-analysis-sales-marketing/novo-nordisk-prevention-digital-tools-and-collaboration-to-define-the-future-of-diabetes/
MSD’s David Peacock on moving UK healthcare forwardDavid Peacock has worked across the world for MSD and other companies, and has now taken the helm Share XMSD’s David Peacock on moving UK healthcare forwardhttps://pharmaphorum.com/views-analysis-sales-marketing/msds-david-peacock-on-moving-uk-healthcare-forward/
Teva’s Kim Innes on shaping the post-COVID future with the NHSLike all UK pharma GMs working during the COVID-19 pandemic, Teva’s Kim Innes has found herself leading her Share XTeva’s Kim Innes on shaping the post-COVID future with the NHShttps://pharmaphorum.com/views-analysis-sales-marketing/teva-kim-innes-on-shaping-the-post-covid-future-with-the-nhs/
Janssen’s Gaëtan Leblay on leading during the COVID-19 crisisCOVID-19 is putting unimaginable pressure on healthcare systems and the companies looking for solutions to end the pandemic. Share XJanssen’s Gaëtan Leblay on leading during the COVID-19 crisishttps://pharmaphorum.com/r-d/views-analysis-r-d/janssens-gaetan-leblay-on-leading-during-the-covid-19-crisis/
Daiichi Sankyo: pharma needs to become NHS ‘experts’If pharma wants to help the NHS improve outcomes, it needs to do so through a true partnership Share XDaiichi Sankyo: pharma needs to become NHS ‘experts’https://pharmaphorum.com/views-analysis-market-access/daiichi-sankyo-pharma-needs-to-become-nhs-experts/
UK Leaders: Gilead’s Hilary Hutton-Squire on building trust with the NHSAs general manager of Gilead UK and Ireland, Hilary Hutton-Squire has been at the forefront of bringing several Share XUK Leaders: Gilead’s Hilary Hutton-Squire on building trust with the NHShttps://pharmaphorum.com/views-analysis-sales-marketing/uk-leaders-gilead-hilary-hutton-squire-on-building-trust-with-the-nhs/
UK leaders: Takeda’s Jon NealIn the first of a new series where we talk to GMs of UK pharma divisions, managing director Share XUK leaders: Takeda’s Jon Nealhttps://pharmaphorum.com/views-analysis-market-access/uk-leaders-takeda-jon-neal/
